Several studies suggested that MST silencing, which consequently impedes the catabolism of products directly derived from CAT enzymatic activity, suppresses cancer cell bioenergetics and/or proliferation in hepatoma and lung carcinoma cell lines [125,143]. This evidence concerns the gene MPST and lung carcinoma.